These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 1104792)

  • 21. The effect of protamine on proteinuria and glomerular sclerosis in aminonucleoside nephropathy.
    Saito T; Yamakage K; Kurosawa K; Kyogoku Y; Furuyama T; Yoshinaga K
    Tohoku J Exp Med; 1982 Apr; 136(4):461-2. PubMed ID: 7101279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aminonucleoside nephrosis in rats. Ultrastructural findings in the glomerulus by concomitant influence of indomethacin and aminonucleoside.
    Sessa A; Conte F; Cioffi A; D'Amico GD
    Nephron; 1975; 14(3-4):299-308. PubMed ID: 1128753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incorporation of 35sulfate into the glomerular basement membrane in puromycin aminonucleoside nephrosis.
    Garin EH; Boggs KP; Burke FC
    Int J Pediatr Nephrol; 1985; 6(2):117-20. PubMed ID: 4030221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alterations in the glomerulus in aminonucleoside nephrosis in analbuminemic rats.
    Abe H; Shibuya T; Odashima S; Arichi S; Nagase S
    Nephron; 1988; 50(4):351-5. PubMed ID: 3237275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endocytosis of cationized horseradish peroxidase by glomerular epithelial cells is reduced in puromycin glomerulopathy.
    Wang Y; Evans B; Thomas JH; Nunan T; Gaunt JI; Morris RW; Davies DR
    Int J Exp Pathol; 1990 Dec; 71(6):823-34. PubMed ID: 2278826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An ultrastructural study of the mechanisms of proteinuria in aminonucleoside nephrosis.
    Ryan GB; Karnovsky MJ
    Kidney Int; 1975 Oct; 8(4):219-32. PubMed ID: 1104966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Podocytes are firmly attached to glomerular basement membrane in kidneys with heavy proteinuria.
    Lahdenkari AT; Lounatmaa K; Patrakka J; Holmberg C; Wartiovaara J; Kestilä M; Koskimies O; Jalanko H
    J Am Soc Nephrol; 2004 Oct; 15(10):2611-8. PubMed ID: 15466265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Podocyte architecture in puromycin aminonucleoside-treated rats administered tungsten or allopurinol.
    Ricardo SD; Bertram JF; Ryan GB
    Exp Nephrol; 1995; 3(5):270-9. PubMed ID: 7583048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antioxidants protect podocyte foot processes in puromycin aminonucleoside-treated rats.
    Ricardo SD; Bertram JF; Ryan GB
    J Am Soc Nephrol; 1994 Jun; 4(12):1974-86. PubMed ID: 7919151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on the relationship between proteinuria and glomerular ultrastructural change in hyperalbuminaemic female Wistar rats.
    Lawrence GM; Brewer DB
    J Pathol; 1982 Dec; 138(4):365-83. PubMed ID: 7175607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased glomerular thromboxane synthesis as a possible cause of proteinuria in experimental nephrosis.
    Remuzzi G; Imberti L; Rossini M; Morelli C; Carminati C; Cattaneo GM; Bertani T
    J Clin Invest; 1985 Jan; 75(1):94-101. PubMed ID: 4038407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nephrotic syndrome induced by dibasic sodium phosphate injections for twenty-eight days in rats.
    Tsuchiya N; Torii M; Narama I; Matsui T
    Toxicol Pathol; 2009 Apr; 37(3):270-9. PubMed ID: 19244217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cationic macromolecule-induced nephrotic syndrome in rabbits. Lack of immune complex involvement.
    Batsford SR; Sasaki M; Takamiya H; Vogt A
    Lab Invest; 1983 Sep; 49(3):260-9. PubMed ID: 6887783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered expression of NDST-1 messenger RNA in puromycin aminonucleoside nephrosis.
    Nakayama K; Natori Y; Sato T; Kimura T; Sugiura A; Sato H; Saito T; Ito S; Natori Y
    J Lab Clin Med; 2004 Feb; 143(2):106-14. PubMed ID: 14966466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-activity relationship for two lipoxygenase inhibitors and their potential for inducing nephrotic syndrome.
    Morley TJ; Evans GO; Goodwin DA; Read NG; Hodgson ST; Hawksworth GM
    Toxicol Appl Pharmacol; 1997 Oct; 146(2):299-308. PubMed ID: 9344898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in the molecular sieve of glomerular basement membrane in rats with aminonucleoside nephrosis.
    Takaya Y; Ota Z; Makino H; Kida K; Miyoshi A; Hiramatsu M; Takahashi K; Ofuji T
    Acta Med Okayama; 1980 Feb; 34(1):67-70. PubMed ID: 6446842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Key molecular events in puromycin aminonucleoside nephrosis rats.
    Guan N; Ding J; Deng J; Zhang J; Yang J
    Pathol Int; 2004 Sep; 54(9):703-11. PubMed ID: 15363039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glomerular sclerosis in nephrotic rats. Comparison of the long-term effects of adriamycin and aminonucleoside.
    Grond J; Weening JJ; Elema JD
    Lab Invest; 1984 Sep; 51(3):277-85. PubMed ID: 6471809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative indexes of aminonucleoside-induced nephrotic syndrome.
    Nevins TE; Gaston T; Basgen JM
    Am J Pathol; 1984 Oct; 117(1):30-6. PubMed ID: 6486243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclosporin reduces proteinuria in rats with aminonucleoside nephrosis.
    Kokui K; Yoshikawa N; Nakamura H; Itoh H
    J Pathol; 1992 Mar; 166(3):297-301. PubMed ID: 1517884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.